Skip to main content
Clinical Trials/NCT04276714
NCT04276714
Terminated
Not Applicable

Revofit™ System and Residual Limb Pain in Amputee Patients : Multiple N-of-1 Trial

University Hospital, Angers1 site in 1 country1 target enrollmentFebruary 22, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Amputation
Sponsor
University Hospital, Angers
Enrollment
1
Locations
1
Primary Endpoint
Pain change assessment
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

At the early stage of the amputation, the residual limb presents post-surgical fluctuations related to post-operative phase, which would need a frequent prosthetic adjustment. In most cases, the volume of residual limb is constant from 12 to 18 months after surgery. However, some daily fluctuations could appear due to an underlying vascular disease for example, which could be painful and impact the quality of life with a constant need of prosthetics adjustment. The goal of this study is to assess the effectiveness of a system-adjusted fitting in comparison with a standard fitting.

Detailed Description

With the " multiple N-of-1 trial " study type, pain, quality of life, functional effects and the patient satisfaction with assistive technology will be assessed for four weeks.

Registry
clinicaltrials.gov
Start Date
February 22, 2021
End Date
March 10, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
University Hospital, Angers
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 years old and above
  • Above knee or below knee amputation (irrespective of etiology and time from amputation)
  • Residual limb pain
  • Prosthetic with classic fitting
  • Fluctuations of residual limb requiring prosthetic adaptation (stump cotton sock, wedgning fitting ...)
  • Recipients or registered with a social security scheme
  • Informed consent form signed beforehand

Exclusion Criteria

  • Patient with peripheral neuropathies contraindicating the use of Revofit system
  • Pregnant woman, nursing mother or parturiant
  • Patient in detention by judicial or administrative decision
  • Patient undergoing psychiatric compulsory care
  • Patient in a health or social institution for purposes other than research
  • Legally protected person
  • Patient unable to express their consent

Outcomes

Primary Outcomes

Pain change assessment

Time Frame: four weeks

Assess the impact of the Revofit™ system adjusted-fitting on residual limb pain compared to a classic fitting with a daily Visual Analog Scale evaluation \[VAS : 0 to 10 which constitues the worst outcome\].

Secondary Outcomes

  • Functional effects in twin task(Once a week during four weeks)
  • Functional effects in simple task(Once a week during four weeks)
  • Everyday comfort(four weeks)
  • Patient satisfaction with assistive technology(Once a week during four weeks)

Study Sites (1)

Loading locations...

Similar Trials